Synthesis and evaluation of the anticonvulsant activity of 8-alkoxy-4,5-dihydrobenzo[b][1,2,4]triazolo[4,3-d][1,4]thiazepine derivatives

Two series of 8-alkoxy-4,5-dihydrobenzo[b][1,2,4]triazolo[4,3-d][1,4]thiazepine derivatives (6a–q and 7a–q) were synthesized and evaluated for their anticonvulsant activity using the maximal electroshock (MES) method. All of the compounds prepared were effective in the MES screens. Among which, compound 7j was considered as the most promising one with an ED50 value of 26.3 mg/kg and a superior protective index value of 12.6. The potency of compound 7j against seizures induced by pentylenetetrazole, 3-mercaptopropionic acid and bicuculline suggested that two different mechanisms of action might potentially be involved in its anticonvulsant activity, including the inhibition of voltage-gated ion channels and the modulation of GABAergic activity. A computational study was also conducted to predict the pharmacokinetic properties of the compounds prepared, with the results supporting the use of these compounds as a group of promising antiepileptic agents.

[1]  J. Sirven,et al.  Antiepileptic drugs 2012: recent advances and trends. , 2012, Mayo Clinic proceedings.

[2]  Ming-Xia Song,et al.  Synthesis and Anticonvulsant Activities of Some Triazolothiadiazole Derivatives , 2012, Archiv der Pharmazie.

[3]  N. Patel,et al.  Antimycobacterial and antimicrobial study of new 1,2,4‐triazoles with benzothiazoles , 2010, Archiv der Pharmazie.

[4]  Ming-Xia Song,et al.  Synthesis and anticonvulsant activity of 7-alkoxy-triazolo-[3, 4-b]benzo[d]thiazoles. , 2010, Medicinal chemistry (Shariqah (United Arab Emirates)).

[5]  Xianqing Deng,et al.  Design and synthesis of 10-alkoxy-5, 6-dihydro-triazolo[4,3-d]benzo[f][1,4]oxazepine derivatives with anticonvulsant activity. , 2010, European journal of medicinal chemistry.

[6]  S. Verma,et al.  Synthesis, anticonvulsant and toxicity screening of newer pyrimidine semicarbazone derivatives. , 2010, European journal of medicinal chemistry.

[7]  J. Stables,et al.  Synthesis, anticonvulsant and antimicrobial activities of some new 2-acetylnaphthalene derivatives. , 2010, Bioorganic & medicinal chemistry.

[8]  Xianqing Deng,et al.  Synthesis and anticonvulsant activity of some 7-alkoxy-2H-1,4-benzothiazin-3(4H)-ones and 7-alkoxy-4H-[1,2,4]triazolo[4,3-d]benzo[b][1,4]thiazines. , 2010, Chemical & pharmaceutical bulletin.

[9]  A. Demirbaş,et al.  Synthesis of some new 1,2,4-triazoles starting from isonicotinic acid hydrazide and evaluation of their antimicrobial activities. , 2009, European journal of medicinal chemistry.

[10]  A. V. Adhikari,et al.  Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety. , 2009, European journal of medicinal chemistry.

[11]  P. Penovich,et al.  Use of a new antiepileptic drug or an old one as first drug for treatment of absence epilepsy , 2009, Epilepsia.

[12]  A. Aldenkamp,et al.  The impact of side effects on long-term retention in three new antiepileptic drugs , 2009, Seizure.

[13]  V. P. Vaidya,et al.  Studies on Synthesis and Pharmacological Activities of 1,2,4‐Triazolo[3,4‐b]1,3,4‐thiadiazoles and their Dihydro Analogues , 2009, Archiv der Pharmazie.

[14]  K. Chai,et al.  Synthesis and Anticonvulsant Activity of 6‐Alkoxy‐[1,2,4]Triazolo[3,4‐a]Phthalazines , 2009, Chemical biology & drug design.

[15]  Li-Ming Zhao,et al.  Design and synthesis of 5-alkoxy-[1,2,4]triazolo[4,3-a]quinoline derivatives with anticonvulsant activity. , 2009, European journal of medicinal chemistry.

[16]  R. Loddo,et al.  In‐Vitro Anti‐HIV and Antitumor Activity of New 3,6‐Disubstituted [1,2,4]Triazolo[3,4‐b][1,3,4]thiadiazoles and Thiadiazine Analogues , 2008, Archiv der Pharmazie.

[17]  Y. Al-Soud Synthesis and anti‐HIV Activity of Substituted 1,2,4‐Triazolo‐thiophene Derivatives. , 2007 .

[18]  René H. Levy,et al.  Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII) , 2007, Epilepsy Research.

[19]  Zhe-shan Quan,et al.  Synthesis and anticonvulsant activity of 7-alkoxyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines. , 2005, Bioorganic & medicinal chemistry letters.

[20]  T. Strine,et al.  Psychological Distress, Comorbidities, and Health Behaviors among U.S. Adults with Seizures: Results from the 2002 National Health Interview Survey , 2005, Epilepsia.

[21]  H. White Preclinical Development of Antiepileptic Drugs: Past, Present, and Future Directions , 2003, Epilepsia.

[22]  J. Gálvez,et al.  Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity. , 2003, Bioorganic & medicinal chemistry letters.

[23]  Anne Hersey,et al.  Rate-Limited Steps of Human Oral Absorption and QSAR Studies , 2002, Pharmaceutical Research.

[24]  G. Estiu,et al.  Pharmacophore model for antiepileptic drugs acting on sodium channels , 2001 .

[25]  E Estrada,et al.  In silico studies for the rational discovery of anticonvulsant compounds. , 2000, Bioorganic & medicinal chemistry.

[26]  P. Selzer,et al.  Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.

[27]  Michał J. Markuszewski,et al.  Brain/blood distribution described by a combination of partition coefficient and molecular mass , 1996 .

[28]  R. D. Lynch,et al.  Structure, function, and regulation of cellular tight junctions. , 1992, The American journal of physiology.

[29]  L. Merlini,et al.  Synthesis and anticonvulsant and sedative-hypnotic activity of 4-(alkylimino)-2,3-dihydro-4H-1-benzopyrans and -benzothiopyrans. , 1990, Journal of medicinal chemistry.

[30]  H. Nagaya,et al.  The role of the nigrotegmental GABAergic pathway in the propagation of pentylenetetrazol-induced seizures , 1989, Brain Research.

[31]  W. Löscher,et al.  Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations , 1988, Epilepsy Research.

[32]  Surendra Singh,et al.  Synthesis of Some New Thiosemicarbazides, Thiadiazoles, Triazoles and Their Derivatives as Potential Antiviral Agents , 1982, Archiv der Pharmazie.

[33]  R. Olsen GABA‐Benzodiazepine‐Barbiturate Receptor Interactions , 1981, Journal of neurochemistry.

[34]  E. Lien,et al.  Quantitative structure-activity relationships and dipole moments of anticonvulsants and CNS depressants. , 1979, Journal of pharmaceutical sciences.

[35]  J. Penry,et al.  Antiepileptic Drug Development: II. Anticonvulsant Drug Screening , 1978, Epilepsia.

[36]  J. Barker,et al.  Specific antagonism of GABA‐mediated postsynaptic inhibition in cultured mammalian spinal cord neurons , 1978, Neurology.

[37]  J. Gaddum,et al.  The Pharmacological Basis of Therapeutics , 1966 .

[38]  Brahim Tabarki,et al.  Antiepileptic drugs , 2014, Reactions Weekly.

[39]  M. Bialer,et al.  Valproic acid: Second generation , 2011, Neurotherapeutics.

[40]  S. Lhatoo,et al.  CNS Adverse Events Associated with Antiepileptic Drugs , 2008, CNS drugs.

[41]  H. Stefan,et al.  Novel anticonvulsant drugs. , 2007, Pharmacology & therapeutics.

[42]  E. Donner,et al.  New generation anticonvulsants for the treatment of epilepsy in children , 2006, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.

[43]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[44]  H. Lankau,et al.  Synthesis, anticonvulsant activity, and structure-activity relationships of sodium channel blocking 3-aminopyrroles. , 1998, Journal of medicinal chemistry.

[45]  K. Luthman,et al.  Correlation of drug absorption with molecular surface properties. , 1996, Journal of pharmaceutical sciences.

[46]  K. Gale,et al.  GABA and epilepsy: basic concepts from preclinical research. , 1992, Epilepsia.

[47]  B. G. White,et al.  Antiepileptic Drug Development Program. , 1984, Cleveland Clinic quarterly.

[48]  W. Löscher 3-Mercaptopropionic acid: convulsant properties, effects on enzymes of the gamma-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine. , 1979, Biochemical pharmacology.